Stocksigma LogoStocksigma Logo

Fischer Medical Ventures Outlines AI-Enabled Healthcare Platform Strategy

Fischer Medical Ventures Ltd released an investor presentation detailing its vertically integrated healthcare platform spanning AI-enabled imaging

Fischer Medical Ventures Outlines AI-Enabled Healthcare Platform Strategy

Fischer Medical Ventures Ltd 路 Intimation 路 07 Sept 2026, 4:50 pm

Fischer Medical Ventures Outlines AI-Enabled Healthcare Platform Strategy Fischer Medical Ventures Ltd released an investor presentation detailing its vertically integrated healthcare platform spanning AI-enabled imaging, population screening, and hospital digitization. Operating via subsidiaries Time Medical and FlynnCare, its portfolio covers MRI (0.35T to 7.0T), CT, portable X-ray, and mammography systems alongside the MIDAS AI screening ecosystem and ATLAS analytics platform. The group also holds strategic stakes across portfolio assets, including Nanyang Biologics (51%), WonderTech (51%), SASCAN (19.9%), and NanoMedic (15%), targeting oncology, neurology, and preventative clinical applications globally across India, SEA, and MENA.

Original exchange filing (PDF)

More announcements from Fischer Medical Ventures Ltd

All Fischer Medical Ventures Ltd announcements